Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
Read MoreIs there a relationship between one’s testosterone levels pretreatment and overall survival for men who get brachytherapy and ADT combined?
Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone Levels
Read MoreIs there a link between ADT and Risk of Heart Failure?
Androgen Deprivation Therapy Use Increases the Risk of Heart Failure in Patients with Prostate Cancer: A Population-Based Cohort Study.
Read MoreDoes the NSAID celecoxib affect survival outcomes of men with advanced prostate cancer?
The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy
Read MoreAre there substantive medical differences between androgen deprivation achieved with LHRH agonist drugs and surgical castration?
Metabolic consequences of gonadotropin-releasing hormone agonists versus orchiectomy: A randomized clinical study
Read MoreIs anti-androgen monotherapy just as good as ADT with LHRH agonists in terms of overall survival?
Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study.
Read MoreADT and Risk of Bone Fractures: What You Should Know
Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures—a study from the fractures and fall injuries in the elderly cohort (FRAILCO)
Read MoreIs there any difference between Lupron and Zoladex?
Effect of hormonal therapy for volume reduction, lower urinary tract symptom relief and voiding symptoms in prostate cancer: leuprolide vs goserelin.
Read MoreWhat is the optimal duration of ADT in men with high-risk prostate cancer, and what factors should be considered?
The Long and Short of It: New Lessons on the Optimal Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer and Where We Need to Go From Here
Read MoreHow likely is ADT to cause anemia?
Mechanisms Responsible for Reduced Erythropoiesis during Androgen Deprivation Therapy in Men with Prostate Cancer
Read More